Bristol myers squibb co stock

Feb 26, 2023 · New York-based Bristol-Myers Squibb (BMY-0.41%) is among the largest pharmaceutical companies in the world. And its stock is a no-brainer buy for investors seeking reliable dividend income. .

BRISTOL-MYERS SQUIBB CO. BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. Bristol-Myers Squibb Co Follow Share $48.90 After Hours: $49.00 (0.20%) +0.100 Closed: Nov 20, 6:58:27 PM GMT-5 · USD · NYSE · Disclaimer search Compare to Pfizer Inc. …

Did you know?

Presently, Bristol-Myers Squibb has more than 30 programs in phase 3 development, including many candidates in key segments like oncology and immunology. Find the latest Bristol-Myers Squibb Company (BMY) stock quote, history, news and other vital information to help you with your stock trading and investing.WebA high-level overview of Bristol-Myers Squibb Company (BMY) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. BMY. Bristol-Myers Squibb Co. 49.60. 0.18. 0.36%. Day; Week; Month; Year. Details. Year-to-Date Change31.06. One-Day Price Change0.18.

Bristol-Myers Squibb has no non-voting common equity. At February 1, 2013, there were 1,637,354,662 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE: Portions of the Proxy Statement for the registrant’s Annual Meeting of Stockholders to be held May 1, 2013 are incorporated by reference into Part III of this Annual ... Bristol-Myers Squibb Company Common Stock. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is ...WebIn addition, the Board of Directors has declared a quarterly dividend of fifty cents ($0.50) per share on the company’s $2.00 convertible preferred stock, payable on December 1, 2023, to ...Bristol-Myers Squibb is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. ... Bristol-Myers Squibb Company. 52.82 +1.69 +3.31%:WebBRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals.

BRISTOL-MYERS SQUIBB CO 0R1F Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals Discover Start …Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis.Web ….

Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. Bristol myers squibb co stock. Possible cause: Not clear bristol myers squibb co stock.

Reconciliations of these non-GAAP financial measures to the most comparable GAAP measures for a particular quarterly period are available on the company’s website at www.bms.com . Find the dividend history information for BMY stock including payable date, record date, amount and dividend type from 1970 until present.Find the latest historical data for Bristol-Myers Squibb Company Common Stock (BMY) at Nasdaq.com.About Bristol Myers Squibb Co. Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers ...

Stock Price Forecast The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 90.00 and a low estimate of 50.00.Warren Buffett's Berkshire Hathaway Inc said on Monday it eliminated its investment in Merck & Co and reduced its stakes in AbbVie Inc and Bristol-Myers Squibb Co , as it pared its overall stock ...WebInformation on stock, financials, earnings, subsidiaries, investors, and executives for Bristol-Myers Squibb. Use the PitchBook Platform to explore the full ...

paper trade options free The company narrowed its earnings outlook to be in the range of $7.50 and $7.65 (versus the $7.35 and $7.65 range earlier). Bristol Myers Squibb’s revenue of $11.0 billion in Q3 was down 2% y-o ...Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. tesla stockworkers compensation insurance providers california Bristol-Myers Squibb has no non-voting common equity. At February 1, 2013, there were 1,637,354,662 shares of common stock outstanding. DOCUMENTS INCORPORATED BY REFERENCE: Portions of the Proxy Statement for the registrant’s Annual Meeting of Stockholders to be held May 1, 2013 are incorporated by reference into Part III of this Annual ... Convert Bristol-Myers Squibb Company stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting. Select a stock. Select a currency. USD. NYSE: Bristol-Myers Squibb Company ( BMY) = 48.72 USD. Provided by Alpha Vantage. best performing fixed income funds Stock Price Forecast The 22 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 60.00, with a high estimate of 90.00 and a low estimate of 50.00.According to our valuation model, Bristol-Myers Squibb Co's stock appears to be modestly undervalued. With a market cap of $129.80 billion, the stock's current price of $62.15 per share is below ... hallador energy stocklargest etfsuinv 0.31%. £57.62B. CELG.RT | Complete Bristol Myers Squibb Co. Rt stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.WebIn connection with this authorization, Bristol-Myers Squibb has entered into accelerated share repurchase (ASR) agreements with Morgan Stanley & Co. LLC and Barclays Bank PLC to repurchase, in aggregate, $7 billion of Bristol-Myers Squibb common stock. Bristol-Myers Squibb expects to fund the repurchase with cash on-hand. iphone delays Complete Bristol Myers Squibb Co. stock information by Barron's. View real-time BMY stock price and news, along with industry-best analysis. highest dividend stocks sandp 500beyond meat stcokcrypto portfolio trackers Nov 20, 2023 · Bristol Myers Squibb ( BMY 1.46%), or BMS for short, is starting the week off on a sour note. Specifically, the drugmaker's shares fell by as much as 4% in early action Monday. BMS' stock has ...